CoChat

Overlap of gastro‐oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population

JUNG, H.‐K., HALDER, S., MCNALLY, M., LOCKE III, G. R., SCHLECK, C. D., ZINSMEISTER, A. R., TALLEY, N. J. · 2007 · Alimentary Pharmacology & Therapeutics
Cited by 125

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Summary: Background Gastro‐oesophageal reflux disease (GERD) and irritable bowel syndrome may occur more often than expected by chance, but little community data exists and risk factors are unknown. Aim To determine prevalence and risk factors for overlap of GERD and irritable bowel disease. Methods Population‐based, cross‐sectional survey was conducted by mailing a valid symptom questionnaire to eligible residents of Olmsted County, MN, aged 30–95 years. Irritable bowel syndrome were defined by Rome III; GERD was defined by weekly or more frequent heartburn and/or acid regurgitation. Results 2298 questionnaires returned (women 52%, 55% response). Irritable bowel syndrome and GERD occurred together more commonly than expected by chance; the prevalence of irritable bowel syndrome–GERD overlap, GERD alone and irritable bowel syndrome alone were 3%, 15% and 5% in men, and 4%, 14% and 10% in women, respectively. Predictors of irritable bowel syndrome–GERD overlap vs. irritable bowel syndrome alone, and separately, GERD alone, were insomnia (OR 1.3, 95% CI: 1.06–1.70; OR 1.5, 95% CI: 1.13–1.90, respectively) and frequent abdominal pain (OR 3.9, 2.2–6.7; OR 1.8, 1.02–3.2, respectively). An additional predictor of irritable bowel syndrome–GERD overlap vs. GERD alone was higher somatization (OR 1.7, 1.1–2.4) and for irritable bowel syndrome–GERD overlap vs. irritable bowel syndrome alone was a higher body mass index (OR 1.0, 1.003–1.07). Conclusions Irritable bowel syndrome and GERD overlap is common in the population and does not occur by chance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2007.03366.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 125

Metadata

Authors
JUNG, H. ‐., HALDER, S., MCNALLY, M., LOCKE III, G. R., SCHLECK, C. D., ZINSMEISTER, A. R., & TALLEY, N. J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2007-05-05
Volume
26
Issue
3
Pages
453-461
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1518671921
Cited by
125
References
13
FWCI
6.14
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Overlap of gastro‐oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. https://app.cochat.ai/papers/10.1111/j.1365-2036.2007.03366.x
The paper
JUNG, H. ‐., HALDER, S., MCNALLY, M., LOCKE III, G. R., SCHLECK, C. D., ZINSMEISTER, A. R., & TALLEY, N. J. (2007). Overlap of gastro‐oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2007.03366.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.